NOL3 is an anti-apoptotic protein, known as an apoptosis repressor with a caspase recruitment domain (ARC) to inhibit caspase-3 and 8, and is increased in the frontal cortex of patients with AD compared with NC34. This evidence concerns the gene NOL3 and Alzheimer disease.